European Journal of Surgical Oncology
Volume 36, Issue 2 , Pages 111-113 , February 2010

A consensus approach to rectal cancer management

  • I. Taylor

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7679 9312; fax: +44 20 7636 5176.

,Accepted 30 July 2009.

References 

  1. Valentini V, Aristei C, Glimelius B, et al. European Rectal Cancer Consensus Conference. EURECA-CC2.
  2. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult: an update. Am J Gastroenterol. 2008;103:1541–1549
  3. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging: a meta-analysis. Radiology. 2004;232:773–783
  4. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497–504
  5. Wolberink SV, Beets-Tan RG, de Haas-Kock DF, et al. Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Dig Dis. 2007;25:80–85
  6. Pomerri F, Maretto I, Pucciarelli S, et al. Prediction of rectal lymph node metastasis by pelvic computed tomography. Eur J Surg Oncol. 2009;35:168–173
  7. Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate?. Lancet Oncol. 2007;8:651–657
  8. Buess GF, Raestrup H. Transanal endoscopic microsurgery. Surg Oncol Clin Am. 2001;10:709–731
  9. Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89:1008–1013
  10. Peeters KC, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693–701
  11. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–820
  12. Pahlman L, Gilmelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990;211:187–195
  13. Birkmeyer JD, Dimick JB. Understanding and reducing variation in surgical mortality. Annu Rev Med. 2008;[Epub ahead of print]
  14. van Gijn W, Wouters MW, Peeters KC, Van de Velde C. Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European Society of Surgical Oncology. J Surg Oncol. 2009;99(8):491–496

PII: S0748-7983(09)00409-0

doi: 10.1016/j.ejso.2009.07.184

European Journal of Surgical Oncology
Volume 36, Issue 2 , Pages 111-113 , February 2010

Article Tools